8 articles
The Delhi High Court has held that Intas Pharmaceuticals' mark CLAVIX constitutes pharmaceutical trademark infringement of Sanofi's blockbuster heart drug mark PLAVIX, differing by just one letter. The…
In the case of ACECLO versus ACECLOHEAL, aceclofenac-derived branding ran into Section 13 and the publici juris problem. Registration didn’t rescue exclusivity, and the visual and market differences…
The Delhi High Court has issued an interim order restraining Rebanta Healthcare from using the REBAHEAL mark following a trademark infringement suit by Dr. Reddy’s. The court found…
The Bombay High Court granted Novartis an injunction against Novarish Healthcare for trademark infringement and passing off. The court found the marks deceptively similar and protected Novartis's established…
This post analyses Delhi High Court decisions on lyricist moral rights, trade dress protection for tablet strips, and trademark revocation in the diabetic sugar sector. The cases underscore…
This article reviews recent Delhi High Court judgments on trademark registration and infringement in India, with a focus on 2021 cases. The analysis covers issues of distinctiveness, confusion…
This bulletin features key trademark developments such as Eris’s acquisition of Novartis trademarks, amendments to China’s Trademark Law, and brand licensing news. It also discusses domain disputes and…
The Delhi High Court addressed the trademark dispute between MUCOSOLVIN and MUCOSOLVAN, focusing on their deceptive similarity and consumer confusion. The judgment provides key insights into trademark protection…